Viruses reproduce by hijacking a living cell’s machinery to copy their own genetic material and build new virus particles. Unlike bacteria or any other organism, a virus cannot replicate on its own. It carries either DNA or RNA as its genome, along with a minimal set of proteins, but it lacks the energy-generating and protein-building equipment that even the simplest cell possesses. Every stage of reproduction, from first contact with a host cell to the release of hundreds or thousands of new particles, depends on commandeering cellular resources. The process unfolds in a series of discrete steps, each of which has become a target for modern antiviral drugs.
Attachment and the Lock-and-Key Problem
Reproduction begins before a virus even enters a cell. The outer surface of every virus carries proteins or protein fragments that recognize and bind to specific molecules on the surface of a host cell. These surface molecules, called receptors, act like locks, and the viral surface proteins act like keys. The match has to be precise: a virus that binds the receptor on a human lung cell usually cannot bind an unrelated receptor on, say, a fish gill cell. This specificity is what determines which species and which tissues a given virus can infect, a concept virologists call tropism.1PubMed Central. Virus-Receptor Interactions: The Key to Cellular Invasion
The attachment step is not just a passive docking event. The binding of viral proteins to host receptors triggers changes in both the virus and the cell that set subsequent steps in motion. Whether a virus can even begin to replicate in your body depends almost entirely on whether the right receptors are present on the right cells.2PubMed Central. Virus-receptor interactions and receptor-mediated virus entry into host cells This is one reason why a cold virus targets your nose and throat rather than your kidneys, and why HIV infects immune cells bearing a particular surface protein rather than muscle cells that lack it.
Getting Inside and Shedding the Coat
Once attached, the virus needs to deliver its genome into the cell’s interior. There are two main routes. Some viruses fuse directly with the cell’s outer membrane, dumping their contents inside the way two soap bubbles merge into one. Others trick the cell into swallowing them whole through a normal intake process called endocytosis, where the cell membrane wraps around the virus and pulls it into an internal compartment. Research has shown that endocytosis is the more common route across viral families, though many viruses can use both pathways depending on conditions.3PubMed Central. Virus entry paradigms
For viruses that enter by endocytosis, the interior of that compartment gradually becomes more acidic. This drop in pH acts as a chemical trigger. Influenza virus, for example, undergoes a two-step uncoating process as pH falls: a first, reversible loosening of its protein shell above pH 6, followed by an irreversible structural collapse below pH 6 that frees the viral genome.4PubMed Central. pH-Controlled two-step uncoating of influenza virus African swine fever virus uses a similar acid-sensing trick, with its major capsid protein physically falling apart at low pH to release the genome from within the viral shell.5bioRxiv. African Swine Fever Virus major capsid p72 Trimers function as a pH sensor during uncoating process of virus endocytosis The general principle holds broadly: the virus uses environmental cues inside the cell to know when and where to undress.
Copying the Genome
This is the step where viral diversity really shows. How a virus copies its genetic material depends on what kind of genetic material it carries, and the strategies are strikingly different.
DNA viruses store their instructions in the same molecule your own cells use. Smaller DNA viruses, like the ones that cause warts, have compact genomes and do not bother encoding their own copying enzyme. Instead, they rely entirely on the host cell’s DNA-copying machinery. Larger DNA viruses, such as herpesviruses and adenoviruses, carry genes for their own DNA-copying enzymes, giving them more independence. Regardless of size, nearly all DNA viruses replicate their genomes inside the cell’s nucleus, where the host’s DNA-processing equipment is concentrated.6PubMed Central. Positive-strand RNA virus replication organelles at a glance
RNA viruses face a different problem. Human cells have no enzyme designed to copy RNA from an RNA template. So RNA viruses must encode their own RNA-copying enzyme, called an RNA-dependent RNA polymerase. Viruses like SARS-CoV-2, dengue, and hepatitis C all belong to a large group of positive-sense RNA viruses that share this basic strategy. These viruses also build specialized compartments inside the cell, called replication organelles, where copying takes place. These tiny structures concentrate the viral copying machinery and shield the replication process from the cell’s immune defenses.6PubMed Central. Positive-strand RNA virus replication organelles at a glance
Retroviruses like HIV add yet another twist. They carry an RNA genome but convert it into DNA using an enzyme called reverse transcriptase. That DNA copy then gets stitched permanently into the host cell’s own chromosomes, becoming part of the cell’s genetic code.7PubMed Central. Beyond reverse transcription: molecular mechanisms and emerging paradigms in retroviral replication Every time the cell divides, it faithfully copies the viral DNA along with its own, which is why HIV infection is lifelong once the virus integrates.
Building New Virus Particles
Once the genome has been copied and viral proteins have been manufactured by the cell’s own protein-building equipment, the components need to come together into new virus particles. For many simple viruses, assembly is remarkably self-directed. Capsid proteins, the building blocks of the virus’s outer shell, have an intrinsic tendency to snap together around the viral genome like the panels of a geodesic dome. Studies using plant viruses have shown that capsid proteins can package RNA molecules of many different lengths, as long as the ratio of protein to RNA is high enough to balance out the electrical charges between them.8PubMed Central. Self-assembly of viral capsid protein and RNA molecules of different sizes: requirement for a specific high protein/RNA mass ratio
Assembly proceeds as a cascade: free protein subunits join a growing cluster one by one, each addition releasing a small amount of energy that favors continued growth. Simulations of this process reveal that the last few subunits are actually the hardest to insert, making the final closure of the shell the slowest step in the whole process.9PubMed. Deciphering the kinetic mechanism of spontaneous self-assembly of icosahedral capsids
For more complex viruses, assembly alone is not enough. The freshly assembled particle often needs to mature, undergoing chemical modifications before it becomes infectious. HIV provides a clear example: after the new virus buds from the cell, a viral enzyme called a protease chops large precursor proteins into their final, functional forms. Without this cleavage step, the virus particle is structurally disorganized and cannot infect a new cell.10PubMed Central. Protease-Mediated Maturation of HIV: Inhibitors of Protease and the Maturation Process SARS-CoV-2 relies on a similar strategy, using its own main protease to cut a long chain of linked proteins at eleven specific sites to generate the individual components needed for a functional virus.11PubMed Central. X-ray crystallographic characterization of the SARS-CoV-2 main protease polyprotein cleavage sites essential for viral processing and maturation
Escaping the Cell
New virus particles are useless if they stay trapped inside the cell that made them. How they get out varies. The textbook image involves the cell bursting open, killed by the sheer volume of new viruses inside it. This lytic release does happen, but it is far from the only exit strategy. Enveloped viruses like influenza and HIV bud gently through the cell membrane, wrapping themselves in a layer of host membrane as they leave, often without immediately killing the cell.
Even among viruses that lack an envelope, which were long assumed to escape only by blowing up the cell, emerging research shows that some can slip out through non-lytic pathways. Certain enteric RNA viruses, the kind that infect the gut, use both lytic and non-lytic exit routes, sometimes at the same time.12PubMed Central. Egress of non-enveloped enteric RNA viruses Non-lytic release lets the host cell survive longer and continue churning out new viruses, which can be an advantage for the virus in terms of total output.
How Viruses Take Over the Cell’s Resources
A recurring theme across viral families is “host shutoff,” where the virus suppresses the cell’s own protein production so that the cellular machinery is freed up to make viral proteins instead. Different viruses accomplish this in different ways. Influenza virus does not appear to preferentially grab the cell’s protein-making machinery. Instead, it floods the cell with so much viral RNA that, by about eight hours after infection, viral messages make up over half of all the RNA being translated. The cell’s own messages get crowded out simply by being outnumbered.13PubMed Central. A systematic view on influenza induced host shutoff
Adenovirus takes a more surgical approach. During its late replication phase, it disables a cellular protein complex that the cell needs to begin translating most of its own messenger RNAs. The virus’s own late-stage messages are built to bypass this complex entirely, so they keep getting translated while the cell’s messages pile up unread.14Cell. Adenovirus inhibition of cellular protein synthesis involves inactivation of cap-binding protein Host shutoff is not just an incidental side effect of infection. It is a widespread, actively evolved strategy that helps viruses win the competition for limited cellular resources.15PubMed Central. Going against the Tide: Selective Cellular Protein Synthesis during Virally Induced Host Shutoff
The cell is not entirely defenseless. Cells have sensors that detect foreign nucleic acids, including viral genomes and the unusual replication products viruses generate. When triggered, these sensors launch immune responses aimed at shutting down the infection and alerting neighboring cells.16PubMed Central. Intracellular detection of viral nucleic acids Much of what we experience as the symptoms of a viral illness, the fever, inflammation, and fatigue, comes from this immune response rather than from direct viral damage.
When Viruses Go Quiet Instead of Replicating
Not every infection leads immediately to a burst of new virus. Some viruses can enter a dormant state called latency, putting their reproduction on hold indefinitely. Herpesviruses are the classic example. After an initial active infection, herpes simplex virus travels along nerve fibers and settles into the cell bodies of sensory neurons, where it can remain silent for years. During latency, the virus expresses almost no proteins, making it essentially invisible to the immune system. It produces small regulatory RNA molecules that keep its own replication genes switched off and prevent the host cell from self-destructing.17PubMed Central. Herpesvirus latency Periodically, the virus reactivates, travels back along the nerve to the skin surface, and produces new virus particles that can spread to other people.18PubMed Central. The molecular basis of herpes simplex virus latency
Bacteriophages, the viruses that infect bacteria, have their own version of this choice. A temperate phage that lands on a bacterial cell can either immediately replicate and destroy its host (the lytic cycle) or integrate its DNA into the bacterial chromosome and ride along quietly as the bacterium divides (the lysogenic cycle). The decision is governed by competing regulatory proteins. In phage lambda, the best-studied example, a protein called CI maintains the quiet state by blocking the genes needed for lytic replication, while a competing protein called Cro can tip the balance toward active reproduction.19PubMed Central. The Developmental Switch in Bacteriophage λ: A Critical Role of the Cro Protein This lytic-lysogenic switch has been found across many phage families infecting different bacterial species, including staphylococci and lactobacilli, suggesting it is a deeply conserved survival strategy.20PubMed. Studies on the gene regulation involved in the lytic-lysogenic switch in Staphylococcus aureus temperate bacteriophage Phi11
Viral Factories and Liquid Compartments
Many viruses do not scatter their replication activities randomly across the cell. Instead, they build concentrated work zones, variously called viral factories, viroplasms, or inclusion bodies. Recent research has revealed that these structures often form through a process called liquid-liquid phase separation, similar to how oil droplets form in water. Viral and host proteins spontaneously condense into dense, liquid-like droplets that concentrate the viral copying machinery, viral genomes, and any host proteins the virus needs, all in one spot.21PubMed. Liquid-liquid Phase Separation in Viral Function
Rotavirus, a common cause of severe diarrhea in young children, provides a well-characterized example. Two of its proteins spontaneously form liquid condensates at the low concentrations reached during normal infection, and these condensates serve as the sites where the viral genome gets copied and new particles begin to assemble.22PubMed Central. Liquid-liquid phase separation underpins the formation of replication factories in rotaviruses Giant viruses like Mimivirus, which are large enough to be visible under a light microscope, build elaborate cytoplasmic factories that resemble nothing so much as a second nucleus inside the host cell. These factories form through multilayered phase separation orchestrated by viral scaffold proteins.23bioRxiv. Nucleocytoviricota viral factories are transient organelles made by liquid-liquid phase separation Mimivirus replicates entirely in the host cytoplasm, never entering the nucleus, an approach it shares with poxviruses like vaccinia.24PubMed Central. Vaccinia-like cytoplasmic replication of the giant Mimivirus
How Antiviral Drugs Target These Steps
Because every stage of the viral life cycle is distinct and essential, each one offers a potential target for drugs. In practice, the most successful antivirals have clustered around a few steps where the virus is most vulnerable or most different from the host cell.
- Entry inhibitors: These block the attachment or fusion step, preventing the virus from getting inside. Drugs like fostemsavir, used against HIV, interfere with the interaction between the viral surface protein and its receptor.
- Polymerase inhibitors: Many antiviral drugs target the enzymes viruses use to copy their genomes. The classic herpesvirus drug acyclovir works by mimicking a DNA building block: the viral copying enzyme incorporates it, and the growing DNA chain stalls. HIV’s reverse transcriptase is the target of a large class of antiretrovirals that work on a similar chain-termination principle.
- Protease inhibitors: Because viruses like HIV and SARS-CoV-2 depend on a protease to cut their large precursor proteins into functional pieces, blocking that protease produces non-infectious particles. The HIV protease inhibitor class transformed the treatment of AIDS, and SARS-CoV-2 protease inhibitors followed the same logic.
- Release inhibitors: The neuraminidase inhibitors used against influenza, such as oseltamivir, block the enzyme influenza uses to detach new virus particles from the cell surface, trapping them and preventing spread to new cells.
The broad-spectrum antiviral ribavirin interferes with genome copying through multiple mechanisms and has been used against several unrelated viruses. Newer agents approved in recent years, including molnupiravir for SARS-CoV-2, continue to exploit the genome-replication step.25PubMed Central. Inhibitors of virus replication: recent developments and prospects The diversity of antiviral targets reflects the fact that viruses are biochemically most exposed, and most distinct from their hosts, during the active phases of their life cycle.
Entities That Blur the Boundaries
The standard life cycle described above applies to conventional viruses, but the edges of virology contain entities that break the rules in interesting ways. Viroids are tiny circles of naked RNA, found only in plants, that carry no protein-coding genes at all. They replicate using the plant cell’s own enzymes through a rolling-circle mechanism, where a continuous copy of the circular genome is made and then chopped into individual units. Some viroids do the chopping themselves using a built-in self-cleaving RNA structure.26PubMed Central. Viroids and Viroid-like Circular RNAs: Do They Descend from Primordial Replicators? Viroids cause real agricultural damage despite being little more than a strand of RNA a few hundred nucleotides long, far simpler than even the smallest virus.
At the other extreme are giant viruses like Mimivirus, whose genomes rival those of small bacteria in size and encode hundreds of proteins, including some involved in translation, a function no conventional virus was thought to possess. The existence of giant viruses with elaborate cytoplasmic replication factories has fueled debate about where viruses sit on the spectrum of life. One long-standing idea is that at least some DNA viruses evolved from once-free-living cells that progressively lost genes as they became parasitic, a path called the reduction hypothesis. Other models propose that viruses, or their ancestors, predate cells entirely and emerged in a primordial world dominated by RNA.27PubMed. The origin of viruses and their possible roles in major evolutionary transitions The truth is probably not one-size-fits-all. Different viral lineages likely have different origins, converging on the shared strategy of obligate parasitism through entirely separate evolutionary routes.